2009
DOI: 10.1039/b821865j
|View full text |Cite
|
Sign up to set email alerts
|

Polymeric nanomedicine for cancer MR imaging and drug delivery

Abstract: Multifunctional nanomedicine is emerging as a highly integrated platform that allows for molecular diagnosis, targeted drug delivery, and simultaneous monitoring and treatment of cancer. Advances in polymer and materials science are critical for the successful development of these multi-component nanocomposites in one particulate system with such a small size confinement (<200 nm). Currently, several nanoscopic therapeutic and diagnostic systems have been translated into clinical practices. In this feature art… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
124
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 166 publications
(128 citation statements)
references
References 145 publications
3
124
0
Order By: Relevance
“…Alternatives to conventional linear polymers evolved rapidly in the 1980s and 90s, as described by a number of research groups, such as Fre´chet and Tomalia for dendritic polymers, [5][6][7][8][9] Eisenberg, Wooley, Bates, Discher and others for polymer micelles, [10][11][12][13][14][15][16][17][18][19][20][21] and Torchilin for polymer modified liposomes. [22][23][24][25][26] In conjunction with advances in polymer synthesis came novel synthetic strategies for the conjugation, encapsulation, release, and imaging 27 of drugs. This review will examine some of the advances in synthetic polymers as drug delivery platforms focusing on PEGylation, and discuss ongoing efforts to improve existing conjugates and diversify the range and targets of drug delivery platforms.…”
Section: Introductionmentioning
confidence: 99%
“…Alternatives to conventional linear polymers evolved rapidly in the 1980s and 90s, as described by a number of research groups, such as Fre´chet and Tomalia for dendritic polymers, [5][6][7][8][9] Eisenberg, Wooley, Bates, Discher and others for polymer micelles, [10][11][12][13][14][15][16][17][18][19][20][21] and Torchilin for polymer modified liposomes. [22][23][24][25][26] In conjunction with advances in polymer synthesis came novel synthetic strategies for the conjugation, encapsulation, release, and imaging 27 of drugs. This review will examine some of the advances in synthetic polymers as drug delivery platforms focusing on PEGylation, and discuss ongoing efforts to improve existing conjugates and diversify the range and targets of drug delivery platforms.…”
Section: Introductionmentioning
confidence: 99%
“…35,36 The physicochemical characteristic of nanoparticles such as particle size directly influences the cellular uptake and distribution, as well as therapeutic efficiency. 37 Particle sizes in different medium at different time intervals were also measured. No significant size fluctuations in Figures 4C-E were observed, indicating that the nanoparticles were stable at 4°C and in the presence of PBS or in RPMI 1640 medium containing 10% FBS.…”
mentioning
confidence: 99%
“…For example, there have recently been advances in the design and synthesis of cell-penetrating and receptor-targeted MR imaging agents. [88][89][90] On the other hand, in the case of luminescent lanthanide complexes, sensors for a targeted analyte can be designed by rationally manipulating the parameters that influence the luminescence of lanthanide complexes, such as varying the number of innersphere water molecules, the distance separating the antenna from the lanthanide ion, the energies of excited states of the antenna, and PeT switches. Thus, a wide variety of analytes can be detected, including pH, ions, reactive oxygen species, and enzymes.…”
Section: Discussionmentioning
confidence: 99%